A yeast-based model of α-synucleinopathy identifies compounds with therapeutic potential

Gerard Griffioen(KU Leuven), Stefaan Wera(KU Leuven), Christophe Pannecouque(Rega Institute for Medical Research), Joris Winderickx(KU Leuven), Piotr Zabrocki(KU Leuven), Hein Duhamel, Klaartje Pellens(KU Leuven), Fred Van Leuven(KU Leuven), Nele Van Damme
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
December 28, 2005
10.1016/j.bbadis.2005.11.009
Cited by 86

Related Papers

Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain
|Journal of Biological Chemistry|1999|668
Serine/threonine protein phosphatases
|Biochemical Journal|1995|637
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
|Journal of Clinical Investigation|2004|622
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice
|Brain|2005|562
Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency
|Proceedings of the National Academy of Sciences|1999|523